Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care products and services to office-based dental, animal health, and medical practitioners, announced today that its Board of Directors has approved a 2-for-1 split of the company's common stock. Each Henry Schein stockholder of record at the close of business on September 1, 2017, will receive a dividend of one additional share for every share held, and trading will begin on a split-adjusted basis on September 15, 2017.

This is Henry Schein's second stock split since its initial public offering in November 1995, with the first split, also 2-for-1, completed in February 2005. Following this second stock split, Henry Schein will have approximately 158 million shares outstanding.

"Our market capitalization and share price have increased considerably over the past dozen years as we have expanded and diversified our business in the U.S. and in certain international markets. We believe this stock split is a testament to our success, and will increase liquidity and make equity ownership in Henry Schein more accessible," said Steven Paladino, Executive Vice President and Chief Financial Officer of Henry Schein.

About Henry Schein, Inc.

Henry Schein, Inc. (Nasdaq: HSIC) is the world's largest provider of health care products and services to office-based dental, animal health, and medical practitioners. The company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites. A Fortune 500® Company and a member of the S&P 500® and the Nasdaq 100® indexes, Henry Schein employs more than 21,000 Team Schein Members and serves more than 1 million customers.